Dupixent® (dupilumab) Late-Breaking Positive Pivotal Data in Bullous Pemphigoid Presented at AAD
Five times more adults on Dupixent achieved sustained disease remission at 36 weeks compared to placebo; significant reductions were also...
Pharmaceutical
Press Release: Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD
Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD Five times more adults on Dupixent achieved sustained disease...
Late-Breaking ESK-001 Phase 2 OLE Data Presented at 2025 AAD Annual Meeting Demonstrate Robust Clinical Responses Over 52-Weeks in Psoriasis
ESK-001 is a highly selective, next-generation oral tyrosine kinase 2 (TYK2) inhibitor currently under development in moderate-to-severe plaque psoriasis and...
Drs. Jeffrey Lieberman, M.D. and David Sinclair, Ph.D. to Present ‘The New Frontier of Longevity Science: Living Well Beyond Your Years’ at SXSW 2025
World-leading authorities explore the potential for extending human lifespan on Monday, March 10 at the JW Marriott AustinAUSTIN, Texas, March 07,...
Curia Announces Strategic Refinancing to Support Continued Growth
ALBANY, N.Y., March 07, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), a leading contract research, development and manufacturing organization,...
RAPT Therapeutics to Participate in Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., March 07, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company...
IDBS Unveils IDBS Polar Control: Revolutionizing Process Management in BioPharmaceutical Development
WOKING, United Kingdom, March 7, 2025 /PRNewswire/ -- IDBS, a leading global provider of cloud software for BioPharma companies, is...
Pharmacy Automation Market worth US$10.00 billion by 2030 with 7.1% CAGR | MarketsandMarkets™
DELRAY BEACH, Fla., March 7, 2025 /PRNewswire/ -- The global Pharmacy Automation Market, valued at US$6.23 billion in 2023, is...
Hospital PMI® at 56%; February 2025 Hospital ISM® Report On Business®
TEMPE, Ariz., March 7, 2025 /PRNewswire/ -- Economic activity in the hospital subsector grew in February for the 18th consecutive month...
Obesity Care Week 2025 Concludes with a Global Commitment to Care
TAMPA, Fla., March 7, 2025 /PRNewswire/ -- As Obesity Care Week (OCW) 2025 comes to a close, organizers and supporters...
Full Circles Therapeutics Secures U.S. Patent Allowance for Targeted Genome Modification Using Circular Single-Stranded DNA
CAMBRIDGE, Mass., March 7, 2025 /PRNewswire/ -- Full Circles Therapeutics, a leader in next-generation genome engineering, announces that the United...
February Recap: 15 Top Health Press Releases
A roundup of the most newsworthy healthcare press releases from PR Newswire, including business strategies shaping the future of healthcare...
Alvotech Meeting Investors and Participates in Fireside Chat At Barclays 27th Global Healthcare Conference in Miami, Florida
REYKJAVIK, Iceland, March 07, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and...
Alvotech Meeting Investors and Participates in Fireside Chat At Barclays 27th Global Healthcare Conference in Miami, Florida
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced...
COEPTIS’ NexGenAI Affiliates Partners with NUBURU Network to Drive Innovation in AI and Robotics as Part of its Transformation Plan
Leveraging Advanced AI and Robotics to Revolutionize Marketing Strategies in Defense and Security SectorsWEXFORD, Pa., March 07, 2025 (GLOBE NEWSWIRE)...
ACARIZAX® approved in Canada for treatment of young children
ALK (ALKB:DC / OMX: ALK B) today announced that Health Canada has approved ALK’s ACARIZAX® tablet for use in children,...
Achieve Life Sciences to Present at the Barclays 27th Annual Global Healthcare Conference
SEATTLE and VANCOUVER, British Columbia, March 07, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty...
Lexicon Pharmaceuticals to Present at the Leerink Partners Global Healthcare Conference 2025
THE WOODLANDS, Texas, March 07, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will...
Molecular Spectroscopy Market Size Booms with CAGR 4.9% and Projected to Reach $5.6 Million by 2030 | Exclusive Report by The Insight Partners
NEW YORK, March 6, 2025 /PRNewswire/ -- According to a comprehensive report from The Insight Partners, "Molecular Spectroscopy Market share and...
Lindus Health and Tiefenbacher Group Launching Clinical Trial to Advance ME/CFS Research and Treatment
BOSTON, March 6, 2025 /PRNewswire/ -- Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials, and Tiefenbacher Group, a leading...